| pubmed-article:8289194 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:8289194 | lifeskim:mentions | umls-concept:C0279516 | lld:lifeskim |
| pubmed-article:8289194 | lifeskim:mentions | umls-concept:C0392747 | lld:lifeskim |
| pubmed-article:8289194 | lifeskim:mentions | umls-concept:C1554963 | lld:lifeskim |
| pubmed-article:8289194 | lifeskim:mentions | umls-concept:C0079411 | lld:lifeskim |
| pubmed-article:8289194 | lifeskim:mentions | umls-concept:C0972266 | lld:lifeskim |
| pubmed-article:8289194 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:8289194 | pubmed:dateCreated | 1994-2-22 | lld:pubmed |
| pubmed-article:8289194 | pubmed:abstractText | This report describes the discovery of a new generation of tetracycline antibacterial agents, the "glycylcyclines". These agents are notable for their activity against a broad spectrum of tetracycline-susceptible and -resistant Gram-negative and Gram-positive aerobic and anaerobic bacteria possessing various classes of tetracycline-resistant determinants [tet B (efflux), tet M (ribosomal protection)]. The design and synthesis of a number of 7-substituted 9-substituted-amido 6-demethyl-6-deoxytetracyclines are described. | lld:pubmed |
| pubmed-article:8289194 | pubmed:language | eng | lld:pubmed |
| pubmed-article:8289194 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8289194 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:8289194 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8289194 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8289194 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8289194 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:8289194 | pubmed:month | Jan | lld:pubmed |
| pubmed-article:8289194 | pubmed:issn | 0022-2623 | lld:pubmed |
| pubmed-article:8289194 | pubmed:author | pubmed-author:BloomJ DJD | lld:pubmed |
| pubmed-article:8289194 | pubmed:author | pubmed-author:TallyF PFP | lld:pubmed |
| pubmed-article:8289194 | pubmed:author | pubmed-author:EllestadG AGA | lld:pubmed |
| pubmed-article:8289194 | pubmed:author | pubmed-author:GluzmanYY | lld:pubmed |
| pubmed-article:8289194 | pubmed:author | pubmed-author:HlavkaJ JJJ | lld:pubmed |
| pubmed-article:8289194 | pubmed:author | pubmed-author:TestaR TRT | lld:pubmed |
| pubmed-article:8289194 | pubmed:author | pubmed-author:LeeV JVJ | lld:pubmed |
| pubmed-article:8289194 | pubmed:author | pubmed-author:RoeR DRD | lld:pubmed |
| pubmed-article:8289194 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:8289194 | pubmed:day | 7 | lld:pubmed |
| pubmed-article:8289194 | pubmed:volume | 37 | lld:pubmed |
| pubmed-article:8289194 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:8289194 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:8289194 | pubmed:pagination | 184-8 | lld:pubmed |
| pubmed-article:8289194 | pubmed:dateRevised | 2003-11-14 | lld:pubmed |
| pubmed-article:8289194 | pubmed:meshHeading | pubmed-meshheading:8289194-... | lld:pubmed |
| pubmed-article:8289194 | pubmed:meshHeading | pubmed-meshheading:8289194-... | lld:pubmed |
| pubmed-article:8289194 | pubmed:meshHeading | pubmed-meshheading:8289194-... | lld:pubmed |
| pubmed-article:8289194 | pubmed:meshHeading | pubmed-meshheading:8289194-... | lld:pubmed |
| pubmed-article:8289194 | pubmed:meshHeading | pubmed-meshheading:8289194-... | lld:pubmed |
| pubmed-article:8289194 | pubmed:meshHeading | pubmed-meshheading:8289194-... | lld:pubmed |
| pubmed-article:8289194 | pubmed:meshHeading | pubmed-meshheading:8289194-... | lld:pubmed |
| pubmed-article:8289194 | pubmed:meshHeading | pubmed-meshheading:8289194-... | lld:pubmed |
| pubmed-article:8289194 | pubmed:meshHeading | pubmed-meshheading:8289194-... | lld:pubmed |
| pubmed-article:8289194 | pubmed:year | 1994 | lld:pubmed |
| pubmed-article:8289194 | pubmed:articleTitle | Glycylcyclines. 1. A new generation of potent antibacterial agents through modification of 9-aminotetracyclines. | lld:pubmed |
| pubmed-article:8289194 | pubmed:affiliation | American Cyanamid Company, Medical Research Division, Pearl River, New York 10965. | lld:pubmed |
| pubmed-article:8289194 | pubmed:publicationType | Journal Article | lld:pubmed |
| http://linkedlifedata.com/r... | http://linkedlifedata.com/r... | pubmed-article:8289194 | lld:chembl |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8289194 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8289194 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8289194 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8289194 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8289194 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8289194 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8289194 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8289194 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8289194 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8289194 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8289194 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8289194 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8289194 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8289194 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8289194 | lld:pubmed |
